Ken Griffin's position in Xeris Biopharma Holdings is currently worth $713 Thousand. That's 0.00% of their equity portfolio (3061st largest holding). The first Xeris Biopharma Holdings trade was made in Q2 2018. Since then Ken Griffin bought shares eight more times and sold shares on eight occasions. The investor's estimated purchase price is $752 Thousand, resulting in a loss of 5.2%.